* Aastrom Biosciences Inc., of Ann Arbor, Mich., named Bruce Husel vice president of quality systems.

* ArQule Inc., of Medford, Mass., named the following to its scientific advisory board: Bruce Ganem, professor of chemistry at Cornell University; Nicos Petasis, associate professor of chemistry at the University of Southern California; and Paul Vouros, professor of chemistry at Northeastern University.

* Arris Pharmaceutical Corp., of South San Francisco, named Ann Welton vice president of biology and preclinical sciences.

* Bristol-Myers Squibb Co., of New York, named Elliot Sigal vice president of applied genomics and drug discovery.

* Chiron Corp., of Emeryville, Calif., named Linda Short vice president of human resources.

* Corvas International Inc., of San Diego, named to its board Douglas Norby, executive vice president and chief financial officer of LSI Logic Corp.

* C.V. Therapeutics Inc., of Palo Alto, Calif., named to its board David Holveck, president and CEO of Centocor Inc., and appointed Daniel Spiegelman vice president and chief financial officer.

* Endorex Corp., of Chicago, named Ricky Wilson executive vice president and chief scientific officer of Wisconsin Genetics, an Endorex subsidiary.

* La Jolla Pharmaceutical Co., of San Diego, named Peter Ulrich executive vice president.

* LXR Biotechnology Inc., of Richmond, Calif., named to its board Neil Flanzraich, a lawyer with Heller Ehrman White & McAuliffe.

* Polydex Pharmaceuticals Inc., of Scarborough, Ontario, named to its board Thomas Ulie, president and CEO of T.R. Ulie & Associates Inc.

* SunPharm Corp., of Jacksonville, Fla., named to its board Jay Moorin, chairman, president and CEO of Magainin Pharmaceuticals Inc.

* Viragen Inc., of Plantation, Fla., named Kenneth Johnson senior medical advisor for multiple sclerosis and neurology.

No Comments